Breast Implant Research Bill Seeks CDRH Postmarket Reports To Congress

Regular updates to Congress from FDA on the status of postmarket evaluations of saline breast implant data would be required under HR 1961, a bill introduced by Reps. Roy Blunt (R-Mo.) and Gene Green (D-Texas) May 23.